ORIC (ORIC Pharmaceuticals) Insider Ownership: 0.88 % (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORIC ORIC Pharmaceuticals Inc ORIC
34 GF Score
Price $13.74
! 4 Warning Signs
View Full Analysis

What is ORIC Pharmaceuticals Insider Ownership?

ORIC Pharmaceuticals ORIC -1.22% 34 Insider Ownership is 0.88 % as of Aug. 27, 2026. GuruFocus rates ORIC with a GF Score™ of 34/100. The stock has 4 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ORIC Pharmaceuticals's insider ownership is 0.88%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ORIC Pharmaceuticals's Institutional Ownership is 115.11%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ORIC Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 98.96%.

ORIC Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for ORIC Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ORIC Pharmaceuticals Insider Ownership Chart

ORIC Pharmaceuticals Historical Data

The historical data trend for ORIC Pharmaceuticals can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 1.20 1.05 0.93 0.83 0.83 0.94 0.81 0.88 0.88 0.88
ORIC
34GF Score
ORIC Pharmaceuticals Inc ORIC
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ORIC Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.88 % mean?
ORIC Pharmaceuticals (ORIC) has a Insider Ownership of 0.88 % as of Aug. 27, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ORIC Pharmaceuticals and its competitors.
Is ORIC Pharmaceuticals' Insider Ownership too high?
ORIC Pharmaceuticals' current Insider Ownership is 0.88 %. Overall, ORIC Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does ORIC Pharmaceuticals' Insider Ownership compare to ARDX and IMTX?
ORIC Pharmaceuticals' Insider Ownership of 0.88 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ORIC Pharmaceuticals and its competitors. ORIC Pharmaceuticals's current Insider Ownership is 0.88 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ORIC Pharmaceuticals stock overvalued right now?
ORIC Pharmaceuticals (ORIC) has a current Insider Ownership of 0.88 %. The current Insider Ownership is 0.88 %. ORIC Pharmaceuticals' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For ORIC Pharmaceuticals (ORIC), the current Insider Ownership is 0.88 % as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ORIC Pharmaceuticals Business Description

Other Exchanges 4TZ:Germany
Address 240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
34GF Score

Get the complete analysis for ORIC

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.74
Price